Urethritis

The US Preventive Services Task Force has released guidelines for the screening of certain populations for Neisseria gonorrhoeae and Chlamydia trachomatis.[40]US Preventive Services Task Force., Davidson KW, Barry MJ, et al. Screening for chlamydia and gonorrhea: US Preventive Services Task Force recommendation statement. JAMA. 2021 Sep 14;326(10):949-56. https://www.doi.org/10.1001/jama.2021.14081 http://www.ncbi.nlm.nih.gov/pubmed/34519796?tool=bestpractice.com There are no recommendations to screen for Trichomonas vaginalis or other causes of nongonococcal urethritis.

Screening for C trachomatisand N gonorrhoeae is recommended on an annual basis for:[1]Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication]. https://www.cdc.gov/std/treatment-guidelines/default.htm ​​[40]US Preventive Services Task Force., Davidson KW, Barry MJ, et al. Screening for chlamydia and gonorrhea: US Preventive Services Task Force recommendation statement. JAMA. 2021 Sep 14;326(10):949-56. https://www.doi.org/10.1001/jama.2021.14081 http://www.ncbi.nlm.nih.gov/pubmed/34519796?tool=bestpractice.com

• All sexually active women aged 24 years or younger; and women ages 25 years and older who are at risk of infection. Risk factors include multiple sex partners, a sex partner with concurrent partners, previous or concurrent STI, and prostitution.

• This recommendation applies to pregnant women.

• There is insufficient evidence to recommend routine screening for heterosexual men; however, at least annual screening should be considered for men who have sex with men.